WHO ICTRP trial
Clinical study on the efficacy and safety of bupivacaine liposome injection for…
ChiCTR2400082230 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2400082230 |
|---|---|
| Public title | Clinical study on the efficacy and safety of bupivacaine liposome injection for regional nerve block in the treatment of postoperative pain in breast cancer patients |
| Scientific title | Clinical study on the efficacy and safety of bupivacaine liposome injection for regional nerve block in the treatment of postoperative pain in breast cancer patients |
| Primary sponsor | Henan Cancer Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 2 |
| Countries | China |
| Conditions | Postoperative pain of breast cancer |
| Interventions | Ropivacaine injection group:Ropivacaine hydrochloride injection;Bupivacaine liposome injection group:Bupivacaine liposome injection |
| Registration date | Mar 25, 2024 |
| Target size | Ropivacaine injection group:55;Bupivacaine liposome injection group:55 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: